QT
LAB icon

Quantamental Technologies’s Standard BioTools LAB Stock Holding History

Quantamental Technologies’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,874
Closed -$35K – 1678
2019
Q2 		$35K Sell
2,874
-2,080
-42% -$26.5K 0.01% 1016
2019
Q1 		$66K Sell
4,954
-2,155
-30% -$22.7K 0.03% 762
2018
Q4 		$61K Buy
+7,109
New +$55.4K 0.04% 726

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Quantamental Technologies's LAB Position: Q3 2019 in Review

Quantamental Technologies sold out of Standard BioTools (LAB) in Q3 2019, closing a stake of 2,874 shares — an estimated $35K sold.

Quantamental Technologies first reported a position in LAB in Q4 2018 and held it in 3 quarters. The position peaked at $66K in Q1 2019. 125 funds tracked by Wall St. Rank hold LAB as of Q3 2019.

  • Quantamental Technologies reported no remaining Standard BioTools position as of Q3 2019 after selling out during the quarter.
  • Quantamental Technologies sold 2,874 Standard BioTools shares in Q3 2019, an estimated $35K.
  • Quantamental Technologies first reported a position in Standard BioTools in Q4 2018 and held it in 3 quarters.
  • Quantamental Technologies's Standard BioTools position peaked at $66K in Q1 2019.
  • 125 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2019.

Based on Quantamental Technologies's 13F filing for Q3 2019, filed 8 Nov 2019.